Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PFE
Stock Latest News
The Fly
Moderately bullish activity in Pfizer with shares up 0.54%
1d ago
PFE
Premium
The Fly
Pfizer price target raised to $36 from $35 at Guggenheim
1d ago
PFE
Premium
Market News
Pfizer’s (PFE) Lyme Vaccine Partner Valneva Stock Crashes 38% despite Trial Success
2d ago
PFE
VALN
Premium
The Fly
Pfizer, Valneva announce ‘positive’ results from Phase 3 VALOR trial
2d ago
PFE
VALN
Premium
Weekend Updates
Pfizer (PFE) Balances Trial Setback With Quiet Pipeline Push
4d ago
PFE
Premium
The Fly
Pfizer recommends shareholders reject mini-tender offer by Tutanota
5d ago
PFE
Premium
The Fly
Pfizer’s talzenna plus xtandi shows improved survival in prostate cancer
6d ago
PFE
Premium
The Fly
Option traders moderately bearish in Pfizer with shares down 0.75%
7d ago
PFE
Premium
Company Announcements
Pfizer Advances Early PF-07328948 Liver Study, Adding Quiet Support to PFE’s Pipeline Story
7d ago
PFE
Premium
Company Announcements
Pfizer Ends Early-Stage Melanoma Study, Trimming One Oncology Bet But Not the Broader Pipeline
7d ago
PFE
Premium
The Fly
Trump Trade: President issues short-term waiver of Jones Act
7d ago
AZN
BMY
Premium
The Fly
Trump claims TrumpRx website offers lowest prices, review says not so, NYT says
7d ago
AZN
BMY
Premium
The Fly
Pfizer announces Phase 2 FOURLIGHT-1 study met primary endpoint
8d ago
PFE
Premium
The Fly
Pfizer price target raised to $32 from $29 at HSBC
8d ago
PFE
Premium
The Fly
District court rules federal limits to vaccines not based on science, NYT says
9d ago
AZN
BMY
Premium
The Fly
Mixed options sentiment in Pfizer with shareslittle changed
9d ago
PFE
Premium
Weekend Updates
Pfizer (PFE) Quietly Arms Pipeline for Next Growth Wave
11d ago
PFE
Premium
The Fly
Mixed options sentiment in Pfizer with shares down 0.43%
12d ago
PFE
Premium
Company Announcements
Pfizer Targets Pediatric Ulcerative Colitis With New Etrasimod Trial: What Investors Should Watch
12d ago
PFE
Premium
Company Announcements
Pfizer’s New Tafamidis Tablet Study Signals Strategic Lifecycle Move for PFE
12d ago
PFE
Premium
Company Announcements
Pfizer Advances Early-Stage Cancer Candidate PF-07994525, Extending Its Oncology Pipeline
13d ago
PFE
Premium
The Fly
Mixed options sentiment in Pfizer with shares down 1.23%
13d ago
PFE
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.